Your Order (0 items)
Your Access to Essential Resources

Fact sheet: Maviret (glecaprevir + pibrentasvir)

 
Fact sheet: Maviret (glecaprevir + pibrentasvir)
CATALOGUE NUMBER: ATI-50279
FORMAT: Fact sheet
DATE OF PUBLICATION: 2018
AUTHOR/PUBLISHER: CATIE
LANGUAGE: English

This fact sheet summarizes up-to-date information on Maviret. Maviret is a medication used to treat hepatitis C. It is approved in Canada for people with hepatitis C in the following situations:

  • those with any genotype of the virus who have never taken direct-acting antiretroviral (DAA) medication
  • those with any genotype of the virus who have taken DAA medication with a type of medicine called an NS5A inhibitor or an NS3/4A protease inhibitor (but not both types of medication) and who were not cured of the virus

Quantity: